CONSOLIDATED STATEMENTS OF OPERATIONS - USD ($) shares in Thousands	12 Months Ended
	Dec. 31, 2023	Dec. 31, 2022
Total revenues	$ 129,998,000	$ 158,803,000
Total costs of revenues	60,403,000	88,648,000
Gross profit	69,595,000	70,155,000
Operating expenses:
Sales and marketing	11,288,000	15,951,000
Research and development	4,367,000	7,888,000
General and administrative	38,884,000	48,755,000
Depreciation and amortization	6,454,000	16,140,000
Stock-based compensation	3,740,000	6,464,000
Goodwill, intangible asset, and other long-lived asset impairments	49,958,000	116,239,000
Acquisition, integration, and transformation costs	44,476,000	20,111,000
Total operating expenses	159,167,000	231,548,000
Loss from operations	(89,572,000)	(161,393,000)
Other income (expense):
Interest expense	(28,195,000)	(26,500,000)
Deconsolidation, Gain (Loss), Amount	59,065,000	(37,708,000)
Loss on extinguishment of debt	0	(14,610,000)
Other income (expense), net, including interest income	1,068,000	7,892,000
Total other income (expense)	31,938,000	(70,926,000)
Net loss before income tax benefit	(57,634,000)	(232,319,000)
Income tax benefit	1,218,000	9,384,000
Net loss	(56,416,000)	(222,935,000)
Less: net income attributable to noncontrolling interests	1,423,000	65,000
Net loss attributable to UpHealth, Inc.	$ (57,839,000)	$ (223,000,000)
Net loss per share attributable to UpHealth, Inc.:
Basic (in dollars per share)	$ (3.26)	$ (15.17)
Diluted (in dollars per share)	$ (3.26)	$ (15.17)
Weighted average shares outstanding:
Basic (in shares)	17,724	14,699
Diluted (in shares)	17,724	14,699
Services
Total revenues	$ 110,039,000	$ 110,953,000
Total costs of revenues	51,073,000	62,954,000
Licenses and subscriptions
Total revenues	6,548,000	12,566,000
Total costs of revenues	1,147,000	1,260,000
Products
Total revenues	13,411,000	35,284,000
Total costs of revenues	$ 8,183,000	$ 24,434,000